Role of PET and SPECT in the study of amyotrophic lateral sclerosis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Cistaro, Angelina ^a,b,c   Cuccurullo, Vincenzo ^d   Quartuccio, Natale ^e   Pagani, Marco ^f   Valentini, Maria Consuelo ^g   Mansi, Luigi ^d  

^a Euromedic Inc   (Italy)

^b PET Pediatric AIMN InterGroup   (Italy)

^c INSTITUTE OF COGNITIVE SCIENCES AND TECHNOLOGIES   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g CTO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE F 18; GLUCOSE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; NEUROTRANSMITTER; RECEPTOR; TRACER;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; BLOOD FLOWMETRY; BRAIN BLOOD FLOW; DIAGNOSTIC IMAGING; EVALUATION STUDY; GLUCOSE METABOLISM; HUMAN; MICROGLIA; MOLECULAR IMAGING; NERVOUS SYSTEM; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN CIRCULATION; METABOLISM; PATHOPHYSIOLOGY; SCINTISCANNING;

AMYOTROPHIC LATERAL SCLEROSIS; CEREBROVASCULAR CIRCULATION; GLUCOSE; HUMANS; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84900301478     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/237437     Document Type: Review

References (45)

1. Cannon W. B., Organization for physiological homeostasis. Physiological Reviews 1929 9 399 431
2. Ereshefsky M., Defining "health" and " disease" Studies in History and Philosophy of Science C:Studies in History and Philosophy of Biological and Biomedical Sciences 2009 40 3 221 227 2-s2.0-69249202233 10.1016/j.shpsc.2009.06.005
3. Jackson S. P., Bartek J., The DNA-damage response in human biology and disease. Nature 2009 461 7267 1071 1078 2-s2.0-70350504453 10.1038/nature08467
4. Mansi L., Ich bin ein Molekularmediziner (how much CT and nuclear medicine in molecular CT?). European Journal of Nuclear Medicine and Molecular Imaging 2009 36 3 531 532 2-s2.0-60549114837 10.1007/s00259-008-1027-3
5. Cascini G. L., Cuccurullo V., Tamburrini O., Rotondo A., Mansi L., Peptide imaging with somatostatin analogues: more than cancer probes. Current Radiopharmaceuticals 2013 6 36 40
6. Cistaro A., Quartuccio N., Vesco S., Pagani M., Fania P., Donati L., Nobili F. M., Duca S., Carrara G., Valentini M. C., Positron emission tomography. Ophthalmology 2012 119 1496 1497
7. Kitson S. L., Cuccurullo V., Moody T. S., Mansi L., Radionuclide antibody-conjugates, a targeted therapy towards cancer. Current Radiopharmaceuticals 2013 6 57 71
8. Benadiba M., Luurtsema G., Wichert-Ana L., Buchpigel C. A., Busatto Filho G., New molecular targets for PET and SPECT imaging in neurodegenerative diseases. Revista Brasileira De Psiquiatria 2012 34 S125 S136
9. Mansi L., Ciarmiello A., Cuccurullo V., PET/MRI and the revolution of the third eye. European Journal of Nuclear Medicine and Molecular Imaging 2012 39 1519 1524
10. Cuccurullo V., Cascini G. L., Tamburrini O., Rotondo A., Mansi L., Bone metastases radiopharmaceuticals: an overview. Current Radiopharmaceuticals 2013 6 41 47
11. Cuccurullo V., Cascini G. L., Mansi L., Structural, pathophysiological and clinical aspects of diagnostic imaging in breast recurrence: the breast after treatment. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 57 322 331
12. Cistaro A., Quartuccio N., Mojtahedi A., Fania P., Filosso P. L., Campenni A., Ficola U., Baldari S., Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing (18)F-FDG PET/CT SUV quantification. Radiology and Oncology 2013 47 219 223
13. Quartuccio N., Treglia G., Salsano M., Mattoli M. V., Muoio B., Piccardo A., Lopci E., Cistaro A., The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma. Radiology and Oncology 2013 47 97 102
14. Cistaro A., Quartuccio N., Mansi L., Signore A., Dolci M., Treglia G., The role of positron emission tomography in Inflammatory bowel disease. European Journal of Inflammation 10 251 256
15. Morbelli S., Perneczky R., Drzezga A., Frisoni G. B., Caroli A., van Berckel B. N., Ossenkoppele R., Guedj E., Didic M., Brugnolo A., Naseri M., Sambuceti G., Pagani M., Nobili F., Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project. Journal of Nuclear Medicine 2013 54 894 902
16. Giovacchini G., Squitieri F., Esmaeilzadeh M., Milano A., Mansi L., Ciarmiello A., PET translates neurophysiology into images: a review to stimulate a network between neuroimaging and basic research. Journal of Cellular Physiology 2011 226 4 948 961 2-s2.0-79251507609 10.1002/jcp.22451
17. Chiò A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B. G., Prognostic factors in ALS: a critical review. Amyotrophic Lateral Sclerosis 2009 10 5-6 310 323 2-s2.0-70450180994 10.3109/17482960802566824
18. Rowland L. P., How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. Archives of Neurology 2001 58 3 512 515 2-s2.0-0035107248 (Pubitemid 32217472)
19. Wijesekera L. C., Leigh P. N., Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases 2009 4 1, article 3 2-s2.0-62749193868 10.1186/1750-1172-4-3
20. Renton A. E., Chiò A., Traynor B. J., State of play in amyotrophic later al sclerosis genetics. Nature Neuroscience 2014 17 17 23
21. Sathasivam S., Motor neurone disease: clinical features, diagnosis, diagnostic pitfalls and prognostic markers. Singapore Medical Journal 2010 51 5 367 373 2-s2.0-79951483000
22. Silani V., Messina S., Poletti B., Morelli C., Doretti A., Ticozzi N., Maderna L., The diagnosis of amyotrophic lateral sclerosis. Archives Italiennes de Biologie 2011 149 1 5 27 2-s2.0-79952823629
23. Ince P. G., Lowe J., Shaw P. J., Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathology and Applied Neurobiology 1998 24 2 104 117 2-s2.0-0031924749 10.1046/j.1365-2990.1998.00108.x (Pubitemid 28175040)
24. Dalakas M. C., Hatazawa J., Brooks R. A., Di Chiro G., Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Annals of Neurology 1987 22 5 580 586 2-s2.0-0023636605 (Pubitemid 17162899)
25. Hatazawa J., Brooks R. A., Dalakas M. C., Mansi L., Di Chiro G., Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study. Journal of Computer Assisted Tomography 1988 12 4 630 636 2-s2.0-0023711665
26. Drayer B. P., Imaging of the aging brain. Part I: normal findings. Radiology 1988 166 3 785 796 2-s2.0-0023856245 (Pubitemid 18058946)
27. Ludolph A. C., Langen K. J., Regard M., Herzog H., Kemper B., Kuwert T., Bottger I. G., Feinendegen L., Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurologica Scandinavica 1992 85 2 81 89 2-s2.0-0026515287
28. Ishikawa K., Nagura H., Yokota T., Yamanouchi H., Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis. Annals of Neurology 1993 33 2 218 222 2-s2.0-0027397903 10.1002/ana.410330214 (Pubitemid 23039933)
29. Shiozawa Z., Shindo K., Ohta E., Ohushi K., Nagamatsu M., Nagasaka T., A concise overview of recent breakthroughs in imaging of ALS. Amyotrophic Lateral Sclerosis 2000 1 2 S3 S6 2-s2.0-0041958532 10.1080/14660820050515647-1
30. Mansi L., Dalakas M. C., DiChiro G., Sever J. L., Patronas N., Bairamian D., Brooks R. A., Jones A. E., Evaluation of cerebral glucose metabolism in patients with amyotrophic lateral sclerosis (ALS) by [18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET). Journal of Nuclear Medicine 1983 24, article P21
31. Abrahams S., Goldstein L. H., Kew J. J. M., Brooks D. J., Lloyd C. M., Frith C. D., Leigh P. N., Frontal lobe dysfunction in amyotrophic lateral sclerosis: a PET study. Brain 1996 119 6 2105 2120 2-s2.0-0030479608
32. Patronas N. J., Di Chiro G., Smith B. H., Depressed cerebellar glucose metabolism in supratentorial tumors. Brain Research 1984 291 1 93 101 2-s2.0-0021365806 10.1016/0006-8993(84)90654-1 (Pubitemid 14221330)
33. Habert M.-O., Lacomblez L., Maksud P., Fakhri G. E. L., Pradat J.-F., Meininger V., Brain perfusion imaging in amyotrophic lateral sclerosis: extent of cortical changes according to the severity and topography of motor impairment. Amyotrophic Lateral Sclerosis 2007 8 1 9 15 2-s2.0-33847376108 10.1080/14660820601048815 (Pubitemid 46331209)
34. Jeong Y., Park K. C., Cho S. S., Kim E. J., Kang S. J., Kim S. E., Kang E., Na D. L., Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease. Neurology 2005 64 4 734 736 2-s2.0-13844320556 (Pubitemid 40261911)
35. Jeong Y., Cho S. S., Park J. M., Kang S. J., Lee J. S., Kang E., Na D. L., Kim S. E., 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. Journal of Nuclear Medicine 2005 46 2 233 239 2-s2.0-15844431849 (Pubitemid 43073429)
36. Cistaro A., Valentini M. C., Chiò A., Nobili F., Calvo A., Moglia C., Montuschi A., Morbelli S., Salmaso D., Fania P., Carrara G., Pagani M., Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. European Journal of Nuclear Medicine and Molecular Imaging 2012 39 2 251 259 2-s2.0-84859631896 10.1007/s00259-011-1979-6
37. Carrara G., Carapelli C., Venturi F., Ferraris M. M., Lequio L., Chiò A., Calvo A., Sirgiovanni S., Cistaro A., Valentini M. C., A distinct MR imaging phenotype in amyotrophic lateral sclerosis: correlation between T1 magnetization transfer contrast hyperintensity along the corticospinal tract and diffusion tensor imaging analysis. American Journal of Neuroradiology 2012 33 4 733 739 2-s2.0-84860260444 10.3174/ajnr.A2855
38. Cistaro A., Pagani M., Montuschi A., Calvo A., Moglia C., Canosa A., Restagno G., Brunetti M., Traynor B. J., Nobili F., Carrara G., Fania P., Lopiano L., Valentini M. C., Chiò A., The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. European Journal of Nuclear Medicine and Molecular Imaging 2014 10.1007/s00259-013-2667-5
39. Sestini S., Castagnoli A., Mansi L., The new FDG brain revolution: the neurovascular unit and the default network. European Journal of Nuclear Medicine and Molecular Imaging 2010 37 5 913 916 2-s2.0-77952093630 10.1007/s00259-009- 1327-2
40. Sestini S., Genetic studies of diseases: the neural basis of functional neuroimaging signal with positron and single-photon emission tomography. Cellular and Molecular Life Sciences 2007 64 14 1778 1784 2-s2.0-34447639410 10.1007/s00018-007-7056-4 (Pubitemid 47093014)
41. Turner M. R., Cagnin A., Turkheimer F. E., Miller C. C. J., Shaw C. E., Brooks D. J., Leigh P. N., Banati R. B., Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiology of Disease 2004 15 3 601 609 2-s2.0-1842471942 10.1016/j.nbd.2003.12.012 (Pubitemid 38429975)
42. Johansson A., Engler H., Blomquist G., Scott B., Wall A., Aquilonius S.-M., Långström B., Askmark H., Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET. Journal of the Neurological Sciences 2007 255 1-2 17 22 2-s2.0-33947201570 10.1016/j.jns.2007.01.057 (Pubitemid 46415796)
43. Lloyd C. M., Richardson M. P., Brooks D. J., Al-Chalabi A., Leigh P. N., Extramotor involvement in ALS: PET studies with the GABA(A) ligand [11C]flumazenil. Brain 2000 123 11 2289 2296 2-s2.0-0033765916
44. Turner M. R., Hammers A., Al-Chalabi A., Shaw C. E., Andersen P. M., Brooks D. J., Leigh P. N., Distinct cerebral lesions in sporadic and "D90A" SOD1 ALS: studies with [11C]flumazenil PET. Brain 2005 128 6 1323 1329 2-s2.0-20444470252 10.1093/brain/awh509 (Pubitemid 40826186)
45. Takahashi H., Snow B. J., Bhatt M. H., Peppard R., Eisen A., Calne D. B., Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. The Lancet 1993 342 8878 1016 1018 2-s2.0-0027358662 10.1016/0140-6736(93)92878-W (Pubitemid 23314803)